Author:
Sghaier Ikram,Zidi Sabrina,El-Ghali Rabeb M.,Daldoul Amira,Aimagambetova Gulzhanat,Almawi Wassim Y.
Subject
Genetics,General Medicine
Reference57 articles.
1. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status;Almeida;Pharmacogenomics J.,2005
2. Amin, M.B., Greene, F.L., Edge, S.B., Compton, C.C., Gershenwald, J.E., Brookland, R.K., et al., 2017. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 67, 93–99.
3. Immunohistochemical markers in breast cancer: a cross-sectional study on triple-negative breast cancer in a rural tertiary care hospital;Ba;Cureus.,2021
4. Breast cancer, estrogen receptor and ligands;Bai;Arch Pharm (Weinheim).,2009
5. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype;Bauer;Cancer.,2007